NCT03593434View on ClinicalTrials.gov

Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Cystic Fibrosis
Interventions
DRUG

hyperpolarized Xenon gas

This present study will utilize existing study visits for the NHLBI study, with patients opting-in to have all of the procedures performed twice, with an intervening ACT, during one their study visits.

Trial Locations (1)

42229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03593434 - Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI | Biotech Hunter | Biotech Hunter